Sodium salt form provides better solubility for injectable and oral formulations, with prolonged activity due to strong plasma protein binding (>99%).
Product Description
| Synonyms | * Sodium N-(5-chloro-4-((4-chlorophenyl)cyanomethyl)-o-tolyl)-2-hydroxy-3,5-diiodobenzamidate, * EINECS 262-794-7 |
| Chemical Name | Sodium N-(5-chloro-4-((4-chlorophenyl)cyanomethyl)-o-tolyl)-2-hydroxy-3,5-diiodobenzamidate |
| Molecular formula | C23H15Cl2I2N2NaO4 |
| Molecular weight | 731.08 |
| CAS No. | 61438-64-0 |
| Structural formula |  |
| Specification |
Appearance: Light yellow powder Identification: IR spectrum conforms to reference standard Sodium identification test: positive Assay (HPLC): 98.0% – 102.0% (on dried basis) Loss on Drying: ≤ 1.0% Residue on Ignition (Sulphated Ash): ≤ 0.2% Related Substances (HPLC): Any individual impurity: ≤ 0.5% Total impurities: ≤ 1.0% pH (1% aqueous solution): 6.0 – 7.5 Heavy Metals: ≤ 20 ppm Solubility: Freely soluble in water; soluble in dimethylformamide; slightly soluble in ethanol |
| Pharmacodynamic Properties |
Mode of Action: Uncouples oxidative phosphorylation in parasite mitochondria, disrupting ATP production and causing parasite death. Spectrum of Activity: Liver flukes (Fasciola hepatica, F. gigantica) Gastrointestinal nematodes (Haemonchus contortus) Blood-sucking ectoparasites (ticks, mites, lice) Pharmacological Advantage: Sodium salt form provides better solubility for injectable and oral formulations, with prolonged activity due to strong plasma protein binding (>99%). |
| Storage | Store in a well-closed container Keep in a cool, dry place away from direct light Recommended storage temperature: below 25 °C |
| MSDS | Provide as per request after the order or contract is signed. |
● Packaging method: 1kg aluminum foil bag, 25kg cardboard or fiber drum, 25kg aluminum tin
● Transportation methods: sea freight, air freight, land freight, international express (DHL, FEDEX, UPS, etc.) are all available
